Decoy Therapeutics Inc. (DCOY)
NASDAQ: DCOY · Real-Time Price · USD
0.9700
-0.0600 (-5.83%)
At close: Oct 23, 2026, 4:00 PM EDT
0.9800
+0.0100 (1.03%)
After-hours: Oct 23, 2026, 7:43 PM EDT
Decoy Therapeutics Revenue
Decoy Therapeutics had revenue of $227.63K in the quarter ending June 30, 2026. This brings the company's total for the last twelve months to $227.63K. That makes Decoy Therapeutics the 45,323rd largest company in the world by revenue and 6,584th in the United States.
Revenue (ttm)
$227.63K
Revenue Growth
n/a
P/S Ratio
2.79
Revenue / Employee
$20,694
Employees
11
Market Cap
635.53K
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | 1.84M | -3.39M | -64.84% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Jaguar Health | 27.82M |
| Scinai Immunotherapeutics | 1.49M |
| SciSparc | 679.00K |
| Biodexa Pharmaceuticals | 104.90K |
| Endovia Health Sciences | 32.09K |
| Virax Biolabs Group | 12.42K |
| Valion Bio | -86.00K |
DCOY News
- 16 days ago - Decoy Therapeutics registers to sell 2.37M shares of common stock for holders - TheFly
- 17 days ago - Decoy Therapeutics Registration statement: Registration filing - Filings
- 24 days ago - Decoy Therapeutics to Present at The Small Cap Showcase - GlobeNewsWire
- 25 days ago - Decoy Therapeutics’ human coronaviruses candidate shows positive PK data - TheFly
- 25 days ago - Decoy Therapeutics Reports Preclinical Data Supporting Once-Weekly Intranasal Dosing for DCOY-CoV Program - PRNewsWire
- 4 weeks ago - Decoy Therapeutics, Inc. Issues Correction to Warrant Inducement Transaction Press Release - PRNewsWire
- 4 weeks ago - Why Is Penny Stock Decoy Therapeutics (DCOY) Up 48% Today? - TipRanks
- 4 weeks ago - Decoy Therapeutics, Inc. Announces a Warrant Inducement Transaction for $3.85 Million in Gross Proceeds Priced At-The-Market under Nasdaq Rules - PRNewsWire